Innovation Pharmaceuticals Inc (IPIX)

[Waverunner1]

I agree on the 3 to 4 yr timeline to reach that kind of valuation (north of $10B) but I think the odds greatly favor a deal on B inside 12-18 mos and that would result in a large step increase potentially in the range of 10X the current valuation. Ultimately, B valuation will of course depend in part on the level of success in the OM trial. In the interim I don't think it would be too hard to get into the $6-$8 range on uplist and addition to the various Russell indices next June if accompanied by continued positive trial results.